SAM #75F40126Q133839

Illumina NextSeq 2000 Sequencing System Service & Maintenance for FDA NCTR

The U.S. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR), Division of Genetic and Molecular Toxicology (DGMT), is seeking a comprehensive service and maintenance agreement for an Illumina NextSeq 2000 Sequencing System. - Government Buyer: - U.S. Food and Drug Administration (FDA) - National Center for Toxicological Research (NCTR) - Division of Genetic and Molecular Toxicology (DGMT) - OEM Highlight: - Illumina is the Original Equipment Manufacturer (OEM) of the NextSeq 2000 Sequencing System - Products/Services Requested: - Corrective/remedial repair and preventive maintenance services for Illumina NextSeq 2000 Sequencing System (Serial Number VH01966) - Service includes: - Unlimited repairs - Preventive maintenance visits - On-site calibration - Technical support - Use of OEM parts and updates - Services must be performed by OEM-certified technicians - Contract Structure: - Firm-fixed price contract - Base year plus four one-year option periods (total potential duration: 5 years) - Notable Requirements: - Only OEM-certified technicians may perform the work - All repairs and maintenance must use OEM parts and updates - Service covers both corrective and preventive maintenance, with unlimited repairs and technical support - Location: - Services to be performed at the FDA NCTR facility in Jefferson, Arkansas

Description

See Attached Combined Synopsis/Solicitation 75F40126Q133839

View original listing